Pharmaceutical Products
Description
AZD-7762 is a novel checkpoint kinase inhibitor with an IC50 of 5 and <10 nM for CHK1 and CHK2, respectively. AZD-7762 significantly prolonged the median time required for tumor volume doubling in response to gemcitabine and radiation. Together, findings suggest that G(2) checkpoint abrogation and homologous recombination repair inhibition both contribute to sensitization by Chk1 inhibition. Furthermore, they support the clinical use of AZD-7762 in combination with gemcitabine and radiation for patients with locally advanced pancreatic cancer.
http://www.chemscene.com/AZD-7762.html
Read More
ChemScene, LLC
ChemScene Pharmaceutical chemical
Address: 11 Deer Park Drive, Suite 102A, Monmouth Junction, NJ 08852,
jersey, new jersey
United States, 07097
Tel: 732-484-9848
Fax: